HIGHLIGHTS
- who: Enhancing Immune Suppression and collaborators from the College of Life and Health Sciences, Northeastern University, Shenyang, Liaoning, China have published the research: PTPN18 Serves as a Potential Oncogene for Glioblastoma by Enhancing Immune Suppression, in the Journal: Oxidative Medicine and Cellular Longevity of 15/02/2023
- what: The authors explored the role of PTPN18 in glioblastoma progression with immune_response. This study demonstrated that the effect and mechanism of PTPN18 on promoting glioblastoma are mediated by reducing immune infiltration and enhancing immune suppression, indicating the potential value of targeting PTPN18 as an immunotherapy strategy for . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.